Quest Diagnostics 1996 Annual Report Download - page 20

Download and view the complete annual report

Please find page 20 of the 1996 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 24

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24

19
Corporate Profile
Quest Diagnostics Incorporated is
one of the leading clinical testing lab-
oratories in the world. With 17
regional labs and 14 smaller branch
labs across the country, Quest
Diagnostics processes and provides
data annually on approximately 60
million requisitions for testing. The
wide variety of tests performed on
human tissue and fluids help doctors
and hospitals diagnose, treat and
monitor diseases and disease states. In
addition, Quest Diagnostics conducts
research through its Nichols Institute
unit, which specializes in esoteric test-
ing using genetic screening and other
advanced technologies, and produces
test kits.
Corporate Headquarters
One Malcolm Avenue
Teterboro, New Jersey 07608
201-393-5000
Additional Information
Investment analysts who need addi-
tional information may contact:
Investor Relations, Quest Diagnostics
Incorporated, One Malcolm Avenue,
Teterboro, New Jersey 07608.
Shareholders may call the toll-free
Quest Diagnostics News and
Information Line at 888-DGX-0002.
Form 10-K
A copy of the Quest Diagnostics 1996
Annual Report on Form 10-K, filed
with the Securities and Exchange
Commission, is contained in this
Annual Report, starting after page 21.
Additional copies are available upon
written request to:
Investor Relations
Quest Diagnostics Incorporated
One Malcolm Avenue
Teterboro, New Jersey 07608.
Common Stock
Shares of Quest Diagnostics
Incorporated common stock (ticker
symbol: “DGX”) are listed on the New
York Stock Exchange and also trade
on the Stuttgart (Germany) Stock
Exchange. Options on Quest
Diagnostics shares are traded on the
Chicago Board Options Exchange.
Transfer Agent and Registrar
[No dividends have been declared
on common stock]
Harris Trust and Savings Bank
Shareholder Services Division
P.O. Box 755
Chicago, Illinois 60690-0755
Telephone: 800-255-0461
For the hearing impaired, Harris
Bank has a Telecommunication
Device for the Deaf (TDD) telephone.
The listing is Harris Bank
Hearing Impaired Telephone
TDD 312-461-5633 or
TDD 312-461-5637.
Change of Address
Report change of address to
Harris Trust and Savings Bank
at the above address.
Independent Accountants
Price Waterhouse LLP
1177 Avenue of the Americas
New York, New York 10036
‘Safe Harbor’ Statement under the Private
Securities Litigation Reform Act of 1995
The statements in this Annual Report
which are not historical facts or infor-
mation are forward-looking state-
ments. These forward-looking state-
ments involve risks and uncertainties
that could cause the outcome to be
materially different. Certain of these
risks and uncertainties are listed on
pages 21 and 22 of the 1996 Annual
Report on Form 10-K contained in
this Annual Report. These risks and
uncertainties include heightened
competition, impact of changes in
payor mix, adverse actions by govern-
mental and other third-party payors,
the impact upon Quest Diagnostics’
collection rates or general or adminis-
trative expenses resulting from com-
pliance with Medicare administrative
policies, adverse results from pending
governmental investigations, reduc-
tion in tests ordered by existing cus-
tomers, material increases in premi-
ums for insurance coverage, denial of
licensure, computer or other system
failures, development of technologies
that substantially alter the practice of
medicine and changes in interest rates.
ANSWERS FOR INVESTORS